NAD+ Dosage: Biomarker Context and Personalized Dosing Framework

Last reviewed: May 29, 2026

Last updated: May 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

NAD+ dosage typically ranges from 250mg to 1000mg per dose depending on delivery method, clinical indication, and individual metabolic factors. There is no universal standard dosage—protocol varies significantly across research literature and clinical practice settings.

Understanding your baseline metabolic status and cellular energy markers matters when considering NAD+ therapy. PlexusDx supports precision wellness by connecting genetic and biomarker insights to treatment planning conversations with qualified healthcare providers.

NAD+ Dosage Ranges Across Delivery Methods

NAD+ is administered via intravenous infusion, intramuscular injection, or oral precursors (NMN, NR). IV protocols often use 500mg to 1000mg per dose, while oral formulations typically range 250mg to 500mg daily. Dosing depends on bioavailability and clinical goal.

Research on longevity and mitochondrial function often employs 250mg to 750mg doses in clinical studies. Individual tolerance, age, and metabolic status influence optimal dosing. A qualified provider should determine appropriate dosage based on your health history and objectives.

Dosage Considerations Across NAD+ Precursors and Administration Routes

Different NAD+ precursors and delivery routes require distinct dosing frameworks. The table below outlines typical clinical dosage ranges, bioavailability factors, and provider considerations for each major approach to NAD+ supplementation.

Delivery Method	Typical Dosage Range	Bioavailability Factors	Clinical Considerations
IV NAD+ Infusion	500–1000mg per dose	100% bioavailable; peak levels immediate	Requires licensed facility; may cause flushing, nausea; weekly to monthly protocols common
Intramuscular NAD+	250–500mg per dose	High absorption; sustained levels 24–48 hours	Easier administration than IV; suitable for home or clinic settings
Oral NMN (precursor)	250–500mg daily	20–30% bioavailability; food affects absorption	Convenient; lower cost; requires consistent daily dosing for cumulative effect
Oral NR (precursor)	250–1000mg daily	19–33% bioavailability; varies by formulation	Most studied oral precursor; GI tolerance varies; timing matters for absorption

Biomarker Assessment and Dosing Personalization

Baseline NAD+ levels, mitochondrial function markers, and metabolic biomarkers can inform dosing decisions. NAD+/NADH ratio, lactate levels, and sirtuins activity provide context for whether standard, conservative, or more aggressive protocols fit your profile.

Genetic variants affecting energy metabolism and nicotinamide metabolism may influence NAD+ responsiveness. PlexusDx's Precision Peptide Genetic Test reveals predispositions in metabolic pathways relevant to cellular energy. These insights should be interpreted with a qualified provider to support more informed dosing discussions.

Safety, Eligibility, and Provider-Guided Dosing Protocols

NAD+ therapy is generally well-tolerated but can cause flushing, nausea, and mild headache—especially with IV infusions. Dosage should be adjusted based on tolerance. Pregnancy, severe kidney/liver disease, and certain medications warrant medical evaluation before starting NAD+ therapy.

A qualified healthcare provider should assess your baseline health status, metabolic markers, and treatment goals before recommending NAD+ dosage. They can review biomarker data, monitor response, and adjust protocols accordingly. Genetic insights may support these conversations but do not replace clinical evaluation.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test may help provide context around metabolic and energy-related predispositions that could inform NAD+ therapy discussions. Variants affecting cellular energy metabolism, mitochondrial function, and nicotinamide utilization can support a more personalized conversation with your provider about whether NAD+ aligns with your wellness goals.

The genetic test reveals predispositions in key metabolic pathways—including genes influencing mitochondrial biogenesis, NAD+ salvage pathways, and sirtuin activity. However, genetic predisposition does not predict exact NAD+ response or optimal dosage. These insights should be interpreted with a qualified healthcare provider as one component of a broader health assessment.

Understanding your genetic predispositions in energy metabolism can help you ask more targeted questions with your provider about NAD+ dosing, monitoring, and timing. Combined with biomarker assessment and clinical history, this information supports a more informed and personalized approach to treatment planning.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $179-$229/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the standard NAD+ dosage for anti-aging or wellness purposes?

There is no universal standard. IV protocols typically use 500–1000mg, while oral precursors range 250–500mg daily. Your provider should determine appropriate dosage based on your health status, biomarkers, and goals.

How does NAD+ bioavailability differ between IV, IM, and oral forms?

IV NAD+ achieves 100% bioavailability immediately. Intramuscular provides high absorption with sustained levels. Oral precursors (NMN, NR) have 19–33% bioavailability and are affected by food and absorption capacity. Route choice depends on accessibility and tolerance.

Can genetic testing help determine my optimal NAD+ dosage?

PlexusDx's Precision Peptide Genetic Test reveals predispositions in metabolic and energy pathways that may provide context for NAD+ discussions. However, genetics predict predisposition, not exact dosage needs. A qualified provider should integrate genetic insights with biomarkers, health history, and clinical assessment.

Are there safety concerns with higher NAD+ dosages?

NAD+ is generally safe, but higher doses increase risk of flushing, nausea, and headache. Individuals with kidney or liver disease should avoid NAD+ therapy. Dosage should be adjusted based on tolerance and provider guidance, not self-adjusted upward.

How often should NAD+ dosing be adjusted based on biomarkers?

Biomarker monitoring (NAD+/NADH ratio, mitochondrial function markers) every 4–8 weeks can inform adjustments. A qualified provider should review your response, tolerance, and changing health status to optimize dosing frequency and amount over time.